Qualigen Therapeutics, Inc.
QLGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,038 | -$1,685 | -$2,646 | -$856 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $9 |
| Change in WC | -$487 | $293 | $936 | -$961 |
| Other Non-Cash | $383 | $295 | $121 | -$462 |
| Operating Cash Flow | -$2,141 | -$1,098 | -$1,589 | -$2,270 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$1,214 | -$305 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$291 | $0 | $0 | -$1,007 |
| Investing Cash Flow | -$291 | -$1,214 | -$305 | -$1,007 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,034 | $2,613 | $750 | -$499 |
| Stock Issued | $41,912 | $3,295 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | -$2 | $0 | $0 |
| Other Fin. Act. | $0 | -$3,293 | $0 | $4,562 |
| Financing Cash Flow | $40,878 | $2,613 | $750 | $4,063 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $38,446 | $301 | -$1,144 | $786 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $332 | $30 | $1,175 | $388 |
| End Cash | $38,777 | $332 | $30 | $1,175 |
| Free Cash Flow | -$2,141 | -$1,098 | -$1,589 | -$2,270 |